Rapid, Selective, and Sensitive LC-MS/MS Method Determines Antioxidant Level in Blood Plasma.
News Jun 06, 2017 | by Adam Tozer PhD
A small team of scientists from China’s Heibei University have developed an LC-MS/MS method for assessing blood plasma concentrations of an antioxidant isolated from paeonies that has been suggested to have therapeutic implications in the treatment of Alzheimer’s Disease.
Benzoylpaeoniflorin (BP) is a potential therapeutic agent against the oxidative stress underlying the neurodegeneration seen in Alzheimer's disease.
In this study, a more rapid, selective, and sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed to determine BP in rat plasma, distinguishing it from the similar monoterpene isomer, benzoylalbiflorin (BA).
The method showed a linear response from 1 to 1000 ng/mL (r > 0.9950). The precision of the interday and intraday ranged from 2.03 to 12.48% and the accuracy values ranged from −8.00 to 10.33%.
Most importantly, the method could be run and finished in 4 minutes.
The LC-MS/MS method was validated for specificity, linearity, precision, accuracy, recovery, and stability and was found to be acceptable for bioanalytical application. As a final test, the fully validated method was successfully applied to a pharmacokinetic study in rats following oral administration.
Zhou, C. and Wang, X. (2017). Rapid Determination of Isomeric Benzoylpaeoniflorin and Benzoylalbiflorin in Rat Plasma by LC-MS/MS Method. International Journal of Analytical Chemistry, 2017, pp.1-9.
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE